Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11560392 Boron-containing compounds

Patent 11560392 was granted and assigned to VenatoRx Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

VenatoRx Pharmaceuticals

Current Assignee

VenatoRx Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115603920

Patent Inventor Names

Yuanqing Fang0

David Ford0

Franz Amann0

Jonas Bürgler0

Matthew M. Bio0

Daniel McGarry0

Date of Patent

January 24, 2023

Patent Application Number

171155140

Date Filed

December 8, 2020

Patent Citations

‌

US Patent 10399996 Beta-lactamase inhibitors

‌

US Patent 10464952 Beta-lactamase inhibitors

‌

US Patent 10479805 Beta-lactamase inhibitor

‌

US Patent 10889600 Boron-containing compounds

‌

US Patent 10669290 Beta-lactamase inhibitors

‌

US Patent 10125152 Beta-lactamase inhibitors

‌

US Patent 10206937 Boronic acid derivatives and therapeutic uses thereof

‌

US Patent 10214547 Beta-lactamase inhibitors

...

Patent Primary Examiner

CPC Code

Described herein are boron-containing compounds, compositions, and methods for their preparation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11560392 Boron-containing compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API